Expression of BCL2L1 in endometrial cancer

UTERINE CORPUS ENDOMETRIAL CARCINOMA (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

BCL2L1 is not prognostic in Uterine Corpus Endometrial Carcinoma (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 72.04

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

5-year survival highⁱ N/A

5-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

56.4

Number of samples

176

Samples

Sample	Description	TPM
TCGA-PG-A7D5-01A	62 years, female, black or african american, stage:Stage IA, alive, 1177 days	211.3
TCGA-AX-A3G3-01A	58 years, female, white, stage:Stage IIIA, alive, 42 days	176.1
TCGA-AJ-A2QO-01A	85 years, female, white, stage:Stage IB, dead, 1045 days	175.8
TCGA-EO-A3AV-01A	51 years, female, stage:Stage IIIC, alive, 1069 days	160.6
TCGA-EY-A4KR-01A	56 years, female, black or african american, stage:Stage IIIC, dead, 346 days	147.4
TCGA-KP-A3W1-01A	76 years, female, stage:Stage IA, alive, 288 days	140.4
TCGA-B5-A3S1-01A	71 years, female, white, stage:Stage IIIC, alive, 902 days	137.5
TCGA-B5-A0JN-01A	84 years, female, black or african american, stage:Stage IVB, alive, 1939 days	127.6
TCGA-D1-A3JP-01A	61 years, female, white, stage:Stage IA, alive, 515 days	119.6
TCGA-AX-A3GI-01A	66 years, female, black or african american, stage:Stage IIIC, alive, 12 days	117.9
TCGA-AX-A3G7-01A	71 years, female, white, stage:Stage IVB, alive, 9 days	105.6
TCGA-FI-A3PX-01A	57 years, female, white, stage:Stage IIIC, alive, 2384 days	103.8
TCGA-AJ-A23N-01A	70 years, female, white, stage:Stage IIIA, dead, 439 days	98.3
TCGA-KP-A3W3-01A	72 years, female, white, stage:Stage IB, alive, 794 days	98.0
TCGA-EO-A3B1-01A	63 years, female, stage:Stage IB, alive, 820 days	97.8
TCGA-EY-A3QX-01A	64 years, female, white, stage:Stage IVB, dead, 989 days	97.2
TCGA-JU-AAVI-01A	61 years, female, black or african american, stage:Stage IIIC, dead, 540 days	96.2
TCGA-B5-A5OD-01A	67 years, female, black or african american, stage:Stage IIIC, alive, 1038 days	94.1
TCGA-EO-A3AU-01A	72 years, female, stage:Stage II, alive, 1543 days	94.0
TCGA-AJ-A8CV-01A	58 years, female, black or african american, stage:Stage IB, alive, 1068 days	89.2
TCGA-AJ-A3IA-01A	77 years, female, white, stage:Stage IB, alive, 633 days	87.9
TCGA-B5-A3FH-01A	74 years, female, black or african american, stage:Stage IA, alive, 841 days	87.0
TCGA-AJ-A3QS-01A	57 years, female, black or african american, stage:Stage IIIA, alive, 513 days	83.0
TCGA-4E-A92E-01A	54 years, female, black or african american, stage:Stage I, alive, 13 days	82.5
TCGA-A5-A7WK-01A	71 years, female, black or african american, stage:Stage IA, alive, 560 days	81.2
TCGA-AJ-A3NG-01A	83 years, female, white, stage:Stage II, alive, 475 days	81.0
TCGA-EO-A3KU-01A	68 years, female, stage:Stage II, alive, 677 days	80.9
TCGA-A5-A2K4-01A	69 years, female, white, stage:Stage IIIA, dead, 871 days	79.9
TCGA-DI-A2QT-01A	51 years, female, american indian or alaska native, stage:Stage IIIC, dead, 377 days	78.6
TCGA-BK-A6W3-01A	34 years, female, black or african american, stage:Stage II, alive, 305 days	76.8
TCGA-AX-A1C7-01A	77 years, female, white, stage:Stage IB, alive, 1054 days	76.8
TCGA-DI-A2QY-01A	64 years, female, white, stage:Stage IIB, dead, 3349 days	76.0
TCGA-AJ-A3OL-01A	55 years, female, white, stage:Stage IIIA, dead, 449 days	74.5
TCGA-AJ-A3EJ-01A	74 years, female, white, stage:Stage IIIC, dead, 50 days	74.2
TCGA-EO-A3AZ-01A	80 years, female, stage:Stage IB, alive, 826 days	73.8
TCGA-A5-A2K7-01A	41 years, female, stage:Stage II, alive, 1063 days	72.1
TCGA-SL-A6JA-01A	77 years, female, black or african american, stage:Stage IB, alive, 7 days	72.0
TCGA-A5-A3LO-01A	64 years, female, white, stage:Stage IB, alive, 776 days	71.6
TCGA-PG-A915-01A	60 years, female, black or african american, stage:Stage IA, alive, 249 days	71.3
TCGA-KP-A3VZ-01A	69 years, female, white, stage:Stage IV, alive, 722 days	71.2
TCGA-EY-A2OQ-01A	61 years, female, white, stage:Stage IA, alive, 885 days	71.0
TCGA-EY-A1GL-01A	51 years, female, white, stage:Stage II, alive, 1014 days	70.5
TCGA-EO-A22U-01A	83 years, female, white, stage:Stage IB, alive, 1407 days	70.3
TCGA-EY-A72D-01A	87 years, female, black or african american, stage:Stage II, alive, 179 days	68.6
TCGA-AJ-A2QM-01A	67 years, female, white, stage:Stage II, alive, 894 days	68.1
TCGA-EO-A3B0-01A	43 years, female, asian, stage:Stage IIIC, alive, 1412 days	67.4
TCGA-AJ-A3NF-01A	60 years, female, white, stage:Stage IIIC, alive, 645 days	66.5
TCGA-AJ-A3TW-01A	78 years, female, white, stage:Stage IB, alive, 513 days	66.1
TCGA-D1-A3JQ-01A	61 years, female, white, stage:Stage IIIC, alive, 526 days	66.0
TCGA-5B-A90C-01A	69 years, female, black or african american, stage:Stage IA, alive, 1202 days	65.8
TCGA-B5-A5OE-01A	68 years, female, black or african american, stage:Stage IIIC, alive, 1063 days	65.5
TCGA-E6-A2P9-01A	65 years, female, white, stage:Stage IA, alive, 1386 days	65.3
TCGA-D1-A3DG-01A	81 years, female, white, stage:Stage IVB, dead, 130 days	64.6
TCGA-D1-A3DA-01A	77 years, female, white, stage:Stage IIIC, alive, 483 days	64.4
TCGA-KP-A3W4-01A	63 years, female, white, stage:Stage IIIA, dead, 554 days	64.0
TCGA-PG-A914-01A	73 years, female, black or african american, stage:Stage IA, alive, 687 days	63.3
TCGA-A5-A1OH-01A	86 years, female, white, stage:Stage IIIA, alive, 1105 days	63.0
TCGA-AJ-A3NE-01A	46 years, female, white, stage:Stage IA, alive, 628 days	62.5
TCGA-DF-A2KN-01A	female, stage:Stage IC, alive, 67 days	62.2
TCGA-AX-A2H4-01A	66 years, female, white, stage:Stage IIIA, dead, 916 days	62.1
TCGA-E6-A2P8-01A	53 years, female, black or african american, stage:Stage IV, dead, 72 days	61.8
TCGA-SJ-A6ZI-01A	64 years, female, black or african american, stage:Stage IB, alive, 631 days	61.4
TCGA-DI-A1BU-01A	55 years, female, white, stage:Stage IIB, alive, 1195 days	61.2
TCGA-QS-A744-01A	86 years, female, black or african american, stage:Stage IIIB, alive, 451 days	60.5
TCGA-FI-A3PV-01A	68 years, female, black or african american, stage:Stage IA, dead, 1249 days	60.4
TCGA-EY-A1GP-01A	54 years, female, black or african american, stage:Stage IA, alive, 573 days	60.1
TCGA-AJ-A8CW-01A	64 years, female, black or african american, stage:Stage IA, alive, 4 days	59.8
TCGA-BK-A6W4-01A	62 years, female, black or african american, stage:Stage IA, alive, 300 days	59.1
TCGA-DF-A2KR-01A	84 years, female, stage:Stage IIIC, alive, 1865 days	58.8
TCGA-EY-A3L3-01A	82 years, female, black or african american, stage:Stage IA, alive, 832 days	57.9
TCGA-AJ-A3BF-01A	65 years, female, white, stage:Stage IIIC, alive, 551 days	57.7
TCGA-AJ-A3NH-01A	90 years, female, white, stage:Stage IB, dead, 1 days	57.7
TCGA-KP-A3W0-01A	72 years, female, stage:Stage IB, alive, 404 days	57.7
TCGA-QS-A5YQ-01A	55 years, female, black or african american, stage:Stage IIIA, alive, 759 days	57.4
TCGA-EY-A54A-01A	67 years, female, black or african american, stage:Stage IIIC, alive, 447 days	56.7
TCGA-B5-A11R-01A	51 years, female, black or african american, stage:Stage II, alive, 2349 days	56.7
TCGA-D1-A2G0-01A	70 years, female, white, stage:Stage IB, alive, 1484 days	56.6
TCGA-BK-A56F-01A	75 years, female, black or african american, stage:Stage IB, alive, 401 days	55.0
TCGA-E6-A8L9-01A	61 years, female, black or african american, stage:Stage IB, alive, 1013 days	55.0
TCGA-EY-A210-01A	82 years, female, black or african american, stage:Stage IIIC, alive, 383 days	52.4
TCGA-EY-A1GX-01A	76 years, female, white, stage:Stage IIIA, dead, 1127 days	52.0
TCGA-SL-A6J9-01A	73 years, female, black or african american, stage:Stage IB, alive, 2 days	51.5
TCGA-BG-A3EW-01A	62 years, female, white, stage:Stage III, alive, 344 days	51.5
TCGA-AJ-A6NU-01A	64 years, female, black or african american, stage:Stage II, alive, 632 days	51.1
TCGA-KJ-A3U4-01A	55 years, female, white, stage:Stage IA, alive, 1095 days	51.0
TCGA-EO-A22X-01A	36 years, female, stage:Stage IIIA, alive, 1752 days	50.9
TCGA-B5-A1MW-01A	55 years, female, white, stage:Stage IA, alive, 447 days	50.9
TCGA-PG-A5BC-01A	72 years, female, black or african american, stage:Stage II, alive, 707 days	50.6
TCGA-BK-A0CA-01A	61 years, female, white, stage:Stage IIIC, alive, 1064 days	49.6
TCGA-AJ-A8CT-01A	58 years, female, black or african american, stage:Stage IA, alive, 82 days	48.9
TCGA-A5-A2K2-01A	77 years, female, white, stage:Stage IA, alive, 3595 days	48.0
TCGA-AJ-A3EK-01A	53 years, female, white, stage:Stage IA, alive, 446 days	47.3
TCGA-B5-A3FA-01A	73 years, female, white, stage:Stage IC, alive, 2929 days	47.2
TCGA-AX-A2IN-01A	63 years, female, white, stage:Stage IC, dead, 947 days	46.9
TCGA-A5-A3LP-01A	74 years, female, white, stage:Stage IB, alive, 455 days	46.5
TCGA-EO-A22Y-01A	68 years, female, white, stage:Stage IA, alive, 1567 days	46.5
TCGA-D1-A3DH-01A	71 years, female, white, stage:Stage IA, alive, 573 days	45.8
TCGA-AJ-A3OJ-01A	54 years, female, white, stage:Stage II, alive, 467 days	45.6
TCGA-BG-A3PP-01A	82 years, female, white, stage:Stage II, alive, 681 days	45.4
TCGA-AX-A3FT-01A	64 years, female, white, stage:Stage IB, alive, 6 days	45.2
TCGA-QS-A5YR-01A	61 years, female, black or african american, stage:Stage IIIB, alive, 719 days	45.0
TCGA-AX-A3G4-01A	60 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, alive, 9 days	44.4
TCGA-EO-A3KX-01A	80 years, female, white, stage:Stage IA, alive, 1170 days	44.3
TCGA-AJ-A5DW-01A	56 years, female, black or african american, stage:Stage IA, alive, 390 days	44.2
TCGA-A5-A7WJ-01A	64 years, female, black or african american, stage:Stage IA, alive, 341 days	44.0
TCGA-EY-A2ON-01A	61 years, female, black or african american, stage:Stage IVB, dead, 610 days	43.6
TCGA-QF-A5YS-01A	57 years, female, black or african american, stage:Stage II, alive, 689 days	43.5
TCGA-AX-A3G6-01A	67 years, female, white, stage:Stage IA, alive, 8 days	43.1
TCGA-QS-A8F1-01A	85 years, female, black or african american, stage:Stage IIIA, dead, 135 days	42.9
TCGA-AJ-A3BG-01A	65 years, female, white, stage:Stage IA, alive, 550 days	42.4
TCGA-DF-A2KZ-01A	87 years, female, stage:Stage IB, alive, 826 days	42.0
TCGA-QF-A5YT-01A	57 years, female, black or african american, stage:Stage II, alive, 1215 days	41.7
TCGA-AX-A3G9-01A	63 years, female, white, stage:Stage IIIC, alive, 558 days	41.2
TCGA-PG-A916-01A	70 years, female, black or african american, stage:Stage I, alive, 522 days	40.7
TCGA-DF-A2KU-01A	female, stage:Stage IB, alive, 3067 days	40.3
TCGA-AJ-A3NC-01A	63 years, female, white, stage:Stage IA, alive, 1125 days	39.9
TCGA-B5-A3FB-01A	73 years, female, black or african american, stage:Stage IB, alive, 2844 days	39.7
TCGA-5S-A9Q8-01A	51 years, female, black or african american, stage:Stage IIIA, alive, 313 days	39.4
TCGA-2E-A9G8-01A	59 years, female, black or african american, stage:Stage III, alive, 1249 days	39.0
TCGA-EO-A3KW-01A	72 years, female, stage:Stage IA, alive, 497 days	39.0
TCGA-B5-A5OC-01A	71 years, female, black or african american, stage:Stage IIIB, alive, 1249 days	38.5
TCGA-B5-A0K9-01A	88 years, female, white, stage:Stage II, dead, 409 days	38.4
TCGA-AJ-A3EL-01A	47 years, female, native hawaiian or other pacific islander, stage:Stage IA, alive, 684 days	37.8
TCGA-BG-A0MK-01A	52 years, female, black or african american, stage:Stage IIB, dead, 1317 days	37.7
TCGA-PG-A6IB-01A	68 years, female, black or african american, stage:Stage IA, alive, 648 days	37.3
TCGA-AJ-A5DV-01A	65 years, female, black or african american, stage:Stage IA, alive, 679 days	37.0
TCGA-EO-A3AS-01A	86 years, female, stage:Stage IA, alive, 1046 days	36.3
TCGA-AX-A3FS-01A	82 years, female, white, stage:Stage IA, alive, 7 days	35.4
TCGA-AJ-A3I9-01A	52 years, female, white, stage:Stage II, dead, 519 days	34.9
TCGA-AX-A3FX-01A	69 years, female, white, stage:Stage IIB, dead, 1333 days	34.8
TCGA-EY-A549-01A	78 years, female, black or african american, stage:Stage IA, alive, 605 days	34.5
TCGA-DF-A2KV-01A	55 years, female, stage:Stage IB, alive, 2717 days	34.4
TCGA-EO-A3AY-01A	58 years, female, stage:Stage IB, alive, 1158 days	34.0
TCGA-A5-A2K3-01A	68 years, female, white, stage:Stage IA, alive, 2012 days	34.0
TCGA-AP-A3K1-01A	56 years, female, white, stage:Stage IVB, dead, 666 days	33.8
TCGA-A5-AB3J-01A	52 years, female, black or african american, stage:Stage II, alive, 512 days	33.6
TCGA-A5-A2K5-01A	76 years, female, white, stage:Stage IA, alive, 752 days	32.5
TCGA-B5-A3F9-01A	56 years, female, black or african american, stage:Stage IB, alive, 4155 days	32.5
TCGA-AX-A3G1-01A	84 years, female, white, stage:Stage IC, dead, 624 days	31.6
TCGA-B5-A3FC-01A	53 years, female, black or african american, stage:Stage II, alive, 2185 days	31.4
TCGA-AJ-A3BD-01A	57 years, female, white, stage:Stage IIIC, alive, 1039 days	31.0
TCGA-DF-A2KY-01A	49 years, female, stage:Stage IVA, alive, 332 days	30.8
TCGA-AX-A3FZ-01A	33 years, female, white, stage:Stage IIIB, alive, 6 days	30.7
TCGA-PG-A917-01A	74 years, female, black or african american, stage:Stage IA, alive, 212 days	30.6
TCGA-EY-A2OO-01A	56 years, female, white, stage:Stage IB, alive, 1392 days	30.0
TCGA-EY-A2OP-01A	63 years, female, white, stage:Stage IA, alive, 944 days	29.3
TCGA-EY-A547-01A	75 years, female, black or african american, stage:Stage IA, alive, 545 days	29.0
TCGA-BK-A139-01A	74 years, female, white, stage:Stage IB, dead, 943 days	28.8
TCGA-BK-A13B-01A	58 years, female, black or african american, stage:Stage IB, alive, 966 days	28.8
TCGA-DF-A2L0-01A	60 years, female, stage:Stage IIIC, dead, 788 days	27.8
TCGA-AX-A2HH-01A	60 years, female, white, stage:Stage IA, alive, 540 days	27.5
TCGA-B5-A0JR-01A	73 years, female, white, stage:Stage IB, alive, 1731 days	27.3
TCGA-B5-A3FD-01A	70 years, female, black or african american, stage:Stage IA, dead, 1197 days	27.0
TCGA-AJ-A3OK-01A	73 years, female, white, stage:Stage IA, alive, 485 days	26.2
TCGA-K6-A3WQ-01A	60 years, female, white, stage:Stage IVB, dead, 427 days	26.0
TCGA-AJ-A3BK-01A	68 years, female, white, stage:Stage IC, alive, 1031 days	25.7
TCGA-AX-A3FW-01A	66 years, female, white, stage:Stage IB, alive, 17 days	25.7
TCGA-EY-A5W2-01A	72 years, female, black or african american, stage:Stage IB, alive, 516 days	24.7
TCGA-EO-A3L0-01A	76 years, female, white, stage:Stage IA, alive, 1554 days	24.5
TCGA-BK-A4ZD-01A	42 years, female, black or african american, stage:Stage IA, alive, 506 days	24.1
TCGA-SJ-A6ZJ-01A	61 years, female, black or african american, stage:Stage IB, alive, 556 days	23.8
TCGA-AJ-A3BI-01A	67 years, female, white, stage:Stage IA, alive, 575 days	23.7
TCGA-EY-A548-01A	83 years, female, black or african american, stage:Stage IA, alive, 430 days	23.5
TCGA-AX-A3GB-01A	73 years, female, white, stage:Stage IB, alive, 440 days	23.3
TCGA-AJ-A3EM-01A	69 years, female, white, stage:Stage IB, alive, 677 days	21.8
TCGA-EO-A1Y7-01A	65 years, female, stage:Stage IB, alive, 1495 days	20.7
TCGA-AX-A3G8-01A	76 years, female, white, stage:Stage IA, alive, 36 days	19.9
TCGA-DI-A1C3-01A	38 years, female, white, stage:Stage IB, alive, 739 days	19.3
TCGA-AP-A5FX-01A	68 years, female, black or african american, stage:Stage IIIC, dead, 1099 days	18.6
TCGA-H5-A2HR-01A	71 years, female, black or african american, stage:Stage IB, alive, 53 days	18.5
TCGA-FI-A2EY-01A	63 years, female, white, stage:Stage IIIA, dead, 880 days	17.7
TCGA-EY-A1GO-01A	65 years, female, white, stage:Stage IIIC, alive, 586 days	16.5
TCGA-BS-A0V4-01A	56 years, female, white, stage:Stage IB, alive, 1810 days	14.0
TCGA-AX-A05W-01A	60 years, female, white, stage:Stage IIB, alive, 2450 days	12.1
TCGA-BS-A0V7-01A	48 years, female, native hawaiian or other pacific islander, stage:Stage IB, alive, 1934 days	11.6
Show allShow less

ENDOMETRIOID ADENOCARCINOMA - Protein relative expression (CPTAC)

Number of samples

153

Samples

Sample ID	Sample type	nRPX
CPT0002210011	Tumor	1.3
CPT0116550004	Tumor	1.0
CPT0022830003	Tumor	0.9
CPT0070380004	Tumor	0.8
CPT0001850012	Tumor	0.8
CPT0002130003	Tumor	0.8
CPT0000730011	Tumor	0.8
CPT0079650003	Tumor	0.8
CPT0022620003	Tumor	0.7
CPT0080980003	Tumor	0.7
CPT0097010003	Tumor	0.7
CPT0080030003	Tumor	0.7
CPT0001460012	Tumor	0.6
CPT0113690003	Tumor	0.5
CPT0027520003	Tumor	0.5
CPT0063790003	Tumor	0.4
CPT0027420003	Tumor	0.4
CPT0076680003	Tumor	0.4
CPT0116630003	Tumor	0.4
CPT0027650003	Tumor	0.4
CPT0018570003	Tumor	0.3
CPT0016220003	Tumor	0.3
CPT0019840003	Tumor	0.3
CPT0076160003	Tumor	0.3
CPT0007600003	Tumor	0.3
CPT0009980003	Tumor	0.3
CPT0075900003	Tumor	0.3
CPT0002500011	Tumor	0.3
CPT0010820003	Tumor	0.3
CPT0017870003	Tumor	0.3
CPT0064210003	Tumor	0.3
CPT0018790003	Tumor	0.2
CPT0063090003	Tumor	0.2
CPT0001140003	Tumor	0.2
CPT0027810003	Tumor	0.2
NX2	Normal	0.2
CPT0064950001	Normal	0.2
CPT0064150004	Tumor	0.2
CPT0063380003	Tumor	0.2
CPT0002080011	Tumor	0.2
CPT0010260003	Tumor	0.2
CPT0077770003	Tumor	0.2
CPT0026530003	Tumor	0.2
CPT0080610003	Tumor	0.2
CPT0075940001	Normal	0.2
CPT0026030004	Tumor	0.2
CPT0016940003	Tumor	0.2
CPT0023810003	Tumor	0.1
CPT0023640001	Normal	0.1
CPT0026780001	Normal	0.1
CPT0063890003	Tumor	0.1
CPT0027970003	Tumor	0.1
CPT0078710004	Tumor	0.1
NX5	Normal	0.0
CPT0078610003	Tumor	0.0
CPT0026270003	Tumor	0.0
CPT0000980012	Tumor	0.0
CPT0070260003	Tumor	0.0
CPT0080300003	Tumor	0.0
CPT0076500003	Tumor	0.0
CPT0022850001	Normal	0.0
CPT0075380003	Tumor	0.0
CPT0063670003	Tumor	0.0
CPT0024130003	Tumor	0.0
CPT0066620003	Tumor	0.0
CPT0097710003	Tumor	0.0
CPT0001470001	Normal	0.0
CPT0080400003	Tumor	0.0
CPT0002430011	Tumor	0.0
CPT0002630003	Tumor	0.0
CPT0026770003	Tumor	0.0
CPT0064320001	Normal	0.0
CPT0010430003	Tumor	0.0
CPT0064290004	Tumor	-0.1
CPT0073730003	Tumor	-0.1
CPT0027320003	Tumor	-0.1
CPT0073450003	Tumor	-0.1
CPT0076860003	Tumor	-0.1
CPT0023630003	Tumor	-0.1
CPT0002010011	Tumor	-0.1
NX8	Normal	-0.1
CPT0022530003	Tumor	-0.1
CPT0010610003	Tumor	-0.1
CPT0026660001	Normal	-0.1
CPT0026430003	Tumor	-0.1
CPT0077780001	Normal	-0.1
CPT0077660001	Normal	-0.1
CPT0077650003	Tumor	-0.1
CPT0064930004	Tumor	-0.1
CPT0116570003	Normal	-0.2
CPT0027020001	Normal	-0.2
CPT0073520003	Tumor	-0.2
CPT0016370003	Tumor	-0.2
NX9	Normal	-0.2
CPT0011020003	Normal	-0.2
CPT0078320004	Tumor	-0.2
CPT0017930001	Normal	-0.2
CPT0080620001	Normal	-0.2
CPT0018960003	Tumor	-0.2
NX7	Normal	-0.2
CPT0064240001	Normal	-0.2
CPT0063250003	Tumor	-0.2
NX4	Normal	-0.2
CPT0015520003	Tumor	-0.2
CPT0073530001	Normal	-0.2
NX3	Normal	-0.2
CPT0027120003	Tumor	-0.3
CPT0016830003	Tumor	-0.3
CPT0027430001	Normal	-0.3
CPT0026540001	Normal	-0.3
CPT0073460001	Normal	-0.3
NX6	Normal	-0.3
CPT0007660001	Normal	-0.3
CPT0063260001	Normal	-0.3
CPT0080700003	Tumor	-0.3
CPT0027130001	Normal	-0.3
CPT0063900001	Normal	-0.3
CPT0093280003	Tumor	-0.3
NX16	Normal	-0.3
CPT0078360001	Normal	-0.3
CPT0002450001	Normal	-0.3
CPT0016490003	Tumor	-0.3
CPT0001300009	Tumor	-0.3
CPT0001420009	Tumor	-0.3
NX1	Normal	-0.3
CPT0011000003	Tumor	-0.3
NX18	Normal	-0.3
NX14	Normal	-0.3
CPT0020530003	Tumor	-0.4
CPT0016530001	Normal	-0.4
CPT0062940003	Tumor	-0.4
CPT0093290000	Normal	-0.4
CPT0070330004	Tumor	-0.4
CPT0063110001	Normal	-0.4
CPT0007100003	Tumor	-0.4
NX12	Normal	-0.4
CPT0080990001	Normal	-0.4
NX17	Normal	-0.5
CPT0080890001	Normal	-0.5
CPT0026650003	Tumor	-0.5
NX15	Normal	-0.5
CPT0021650003	Tumor	-0.6
CPT0001910016	Tumor	-0.6
NX10	Normal	-0.7
NX11	Normal	-0.7
NX13	Normal	-0.7
CPT0016260003	Tumor	-0.7
CPT0080880003	Tumor	-1.0
CPT0002560003	Tumor	-1.6
CPT0079570003	Tumor	N/A
CPT0078880003	Tumor	N/A
CPT0097730003	Tumor	N/A
CPT0000820012	Tumor	N/A
Show allShow less

UTERINE CORPUS ENDOMETRIAL CARCINOMA - Protein relative expression (CPTAC)

Number of samples

160

Samples

Sample ID	Sample type	nRPX
CPT0186720008	Tumor	1.1
CPT0093170003	Tumor	1.1
CPT0197250003	Tumor	0.9
CPT0188610003	Tumor	0.9
CPT0186010004	Tumor	0.9
CPT0288750003	Tumor	0.8
CPT0238260003	Tumor	0.8
CPT0186900008	Tumor	0.7
CPT0225010003	Tumor	0.7
CPT0097300003	Tumor	0.6
CPT0133400008	Tumor	0.6
CPT0181320003	Tumor	0.6
CPT0117010004	Tumor	0.6
CPT0182020004	Tumor	0.6
CPT0188370003	Tumor	0.5
CPT0190700008	Tumor	0.5
CPT0092460003	Tumor	0.5
CPT0172200008	Tumor	0.4
CPT0181960004	Tumor	0.4
CPT0095130004	Tumor	0.4
CPT0159220008	Tumor	0.4
CPT0265110003	Tumor	0.4
CPT0128370003	Tumor	0.3
CPT0127980003	Tumor	0.3
CPT0113850003	Tumor	0.3
CPT0129520003	Tumor	0.3
CPT0095100003	Tumor	0.3
CPT0188270004	Tumor	0.3
CPT0086090003	Tumor	0.3
CPT0083580003	Tumor	0.3
CPT0174890008	Tumor	0.2
NX037	Normal	0.2
CPT0188190004	Tumor	0.2
CPT0182070004	Tumor	0.2
NX036	Normal	0.2
CPT0091780003	Tumor	0.2
CPT0234080003	Tumor	0.2
CPT0247880003	Tumor	0.2
CPT0092690003	Tumor	0.2
CPT0117300003	Tumor	0.2
CPT0115000004	Tumor	0.2
CPT0095230003	Tumor	0.2
CPT0089600003	Tumor	0.2
CPT0196790004	Tumor	0.2
CPT0128770003	Tumor	0.2
CPT0181670008	Tumor	0.2
NX023	Normal	0.2
CPT0188480004	Tumor	0.2
CPT0099910003	Tumor	0.2
CPT0116340004	Tumor	0.2
CPT0226810003	Tumor	0.2
CPT0128960003	Tumor	0.2
CPT0158520008	Tumor	0.1
CPT0129640003	Tumor	0.1
CPT0247910003	Tumor	0.1
CPT0182290003	Tumor	0.1
CPT0181810004	Tumor	0.1
CPT0116250004	Tumor	0.1
CPT0112910003	Tumor	0.1
CPT0134500003	Tumor	0.1
NX031	Normal	0.1
NX026	Normal	0.1
CPT0182210004	Tumor	0.1
CPT0128610003	Tumor	0.1
CPT0203150008	Tumor	0.1
CPT0104690003	Tumor	0.1
CPT0115530003	Tumor	0.1
CPT0113330003	Tumor	0.1
CPT0244510003	Tumor	0.1
CPT0111950003	Tumor	0.1
CPT0288830003	Tumor	0.0
NX038	Normal	0.0
CPT0186560008	Tumor	0.0
CPT0127700003	Tumor	0.0
CPT0098920003	Tumor	0.0
CPT0203250008	Tumor	0.0
CPT0188100004	Tumor	0.0
CPT0182150003	Tumor	0.0
CPT0226860003	Tumor	0.0
CPT0275270003.1	Tumor	0.0
CPT0092860003	Tumor	0.0
CPT0117370004	Tumor	0.0
CPT0111810003	Tumor	0.0
CPT0117230003	Tumor	0.0
CPT0095190003	Tumor	0.0
CPT0187960004	Tumor	0.0
CPT0088140003	Tumor	0.0
CPT0091990003	Tumor	0.0
CPT0112780003	Tumor	0.0
CPT0116940003	Tumor	0.0
CPT0248000003	Tumor	-0.1
CPT0129080003	Tumor	-0.1
CPT0171090008	Tumor	-0.1
NX020	Normal	-0.1
CPT0116010004	Tumor	-0.1
CPT0247970003	Tumor	-0.1
CPT0211120004	Tumor	-0.1
NX027	Normal	-0.1
CPT0182340004	Tumor	-0.1
CPT0114340003	Tumor	-0.1
CPT0111880003	Tumor	-0.1
CPT0087260003	Tumor	-0.1
CPT0113910003	Tumor	-0.1
CPT0108750003	Tumor	-0.1
CPT0095280003	Tumor	-0.1
CPT0115470003	Tumor	-0.1
CPT0117560003	Tumor	-0.1
CPT0181540008	Tumor	-0.1
CPT0100100003	Tumor	-0.1
CPT0117510003	Tumor	-0.1
CPT0159110003	Tumor	-0.1
CPT0104820003	Tumor	-0.1
CPT0188030003	Tumor	-0.1
CPT0247940003	Tumor	-0.1
NX032	Normal	-0.1
CPT0086490003	Tumor	-0.1
NX029	Normal	-0.1
CPT0244470003.1	Tumor	-0.2
CPT0096010003	Tumor	-0.2
CPT0111720003	Tumor	-0.2
CPT0116140004	Tumor	-0.2
NX033	Normal	-0.2
CPT0161590008	Tumor	-0.2
CPT0113060003	Tumor	-0.2
NX024	Normal	-0.2
CPT0127610003	Tumor	-0.2
CPT0181610003	Tumor	-0.2
CPT0100010003	Tumor	-0.3
NX035	Normal	-0.3
CPT0126000003	Tumor	-0.3
CPT0133770008	Tumor	-0.3
CPT0091910003	Tumor	-0.3
CPT0181750004	Tumor	-0.3
CPT0265300003	Tumor	-0.3
CPT0188710003	Tumor	-0.3
NX030	Normal	-0.3
CPT0133600003	Tumor	-0.3
CPT0116710003	Tumor	-0.3
CPT0113430004	Tumor	-0.3
CPT0098270003	Tumor	-0.3
CPT0203040008	Tumor	-0.3
NX028	Normal	-0.4
NX025	Normal	-0.4
CPT0095880003	Tumor	-0.4
NX034	Normal	-0.4
CPT0117440003	Tumor	-0.4
CPT0097440003	Tumor	-0.4
NX021	Normal	-0.4
CPT0134310008	Tumor	-0.4
NX019	Normal	-0.5
CPT0099050003	Tumor	-0.5
CPT0136280003	Tumor	-0.5
NX022	Normal	-0.5
CPT0137140008	Tumor	-0.5
CPT0182380004	Tumor	-0.5
CPT0172460008	Tumor	-0.6
CPT0091720003	Tumor	-0.6
CPT0114100003	Tumor	-0.7
CPT0244470003	Tumor	N/A
CPT0275270003	Tumor	N/A
Show allShow less

ENDOMETRIAL CANCER - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA035734
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Adenocarcinoma, NOS